Anlon Healthcare Ltd.

15.16

0.1 (0.7%)stock indicator image for upward trend

As on July 15, 2026
SectorNA
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap804 Cr
P/E Ratio29.44
Dividend YieldN/A
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

This image for unlock stock of the monthUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open15.12
High15.29
NSE SymbolAHCL
Close15.16
Low15.11
BSE Symbol544497
Previous Years High/Low
1 Year High17.27
3 Year High17.27
5 Year High17.27
1 Year Low9.08
3 Year Low9.08
5 Year Low9.08

Technicals


IndicatorsValueSignal
5-DMA15.33Bearish
10-DMA15.46Bearish
20-DMA15.75Bearish
50-DMA14.69Bullish
100-DMA13.52Bullish
200-DMA13.62Bullish

Historical Performance


1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 29.44, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered price CAGR data is unavailable.
  • The stock carries a low beta of 0.6, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported an EBITDA of ₹327 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹1203 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 1652676.3
No. of Shares: 109016 (Approx)
Performance:65.3%
652676.3
NIFTY Performance: -4.5%
1 day Top Gainers
SymbolChange%
NUVOCO377.25(11%)
AEGISLOG1321.1(8%)
ATHERENERG1296.4(8%)
LTTS3508.3(7%)
INOXINDIA1964.4(6%)
1 Day Top Losers
SymbolChange%
PATANJALI347.9(-15%)
TATAELXSI3520.4(-5%)
DBREALTY116.87(-5%)
ADANIPOWER218.97(-3%)
ADANIGREEN1555.4(-3%)
GODIGIT298.65(-3%)
JSWINFRA337.35(-3%)
ZENSARTECH513.1(-3%)

Top Performing Stocks from the same sector


Ind-Swift Laboratories Ltd.

40.2%

226.82

1 Month Performance

Bafna Pharmaceuticals Ltd.

38.1%

217.12

1 Month Performance

Unichem Laboratories Ltd.

35.3%

595.1

1 Month Performance

RPG Life Sciences Ltd.

29.6%

2978.1

1 Month Performance

Wanbury Ltd.

29%

344.75

1 Month Performance

Hikal Ltd.

28.6%

240.8

1 Month Performance

Beta Drugs Ltd.

25.6%

2305

1 Month Performance

IOL Chemicals And Pharmaceuticals Ltd.

24.1%

165.7

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month